SV

Street Verdict

Analyst Scorecard

SAGILITY · NSE

SAGILITY LIMITED

₹45.25

+0.87% (+₹0.39)

Prev. close

₹44.86

Volume

4,22,05,390

Delivery %

50.6%

As of

20 Nov 2026

Price history

₹45.25+₹3.09 (+7.33%) · 3M
18 Aug 2026 → 20 Nov 2026
434445464718 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

Analysts lean bullish

6 analyst stances · last 90 days · one per analyst

Trackable

5 · 5 bull / 0 neutral / 0 bear

Long-Horizon

none in range

Commentary

1 · 1 bull / 0 neutral / 0 bear

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (6)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 3 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About SAGILITY LIMITED

Sagility Limited engages in the rendering voice and non-voice business process management and back-office transaction processing services in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims and membership managed services, such as digital mailroom, product and plan configuration, enrollment and billing, adjudication and adjustment, and appeals management solutions; engagement services; and payer clincal services. It also provides network operations suite comprising provider credentialing, provider data management, provider accuracy, and provider forward solutions; healthcare consulting services; sagility synchrony; healthcare payment integrity services; and provider services that includes patient access, clinical denials management, revenue cycle management, patient engagement, and coding solutions. In addition, the company offers member lifecycle management, provider lifecycle management, claims management, clinical utilization and care management, payment integrity, and provider revenue cycle management solutions. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. Sagility Limited was incorporated in 2021 and is based in Bengaluru, India. The company operates as a subsidiary of Sagility B.V.

Details

Sector

Healthcare

Industry

Health Information Services

CEO

Mr. Ramesh Gopalan

Headquarters

Bengaluru

Employees

51,486

Key stats

Market cap

₹20,405.91 Cr

P/E ratio (TTM)

19.8

Dividend yield

0.71%

EPS (TTM)

₹2.20

Beta (1Y · daily vs NIFTY 50)

0.92

Shares float

228.53 Cr

EPS · quarter ended Sept 2026

₹0.61

Financial Performance

01 · Financials

0 Cr2500 Cr5000 Cr7500 Cr₹0%5%10%15%FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

00.511.52₹FY23FY24FY25FY26

03 · Dividend Profile

0000₹0%0.3%0.5%0.8%12 Nov 2507 Aug 2630 Oct 26
Dividend (₹/share)Annualised yield

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-20%0%20%40%FY24FY25FY26
SalesFixed assetsTrade receivables

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr5000 Cr10000 Cr15000 Cr₹0×0.25×0.5×0.75×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr5000 Cr10000 Cr15000 Cr₹FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

0 Cr1000 Cr2000 Cr3000 Cr₹FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY23FY24FY25FY26
₹4,218.41 Cr₹4,753.56 Cr₹5,569.92 Cr₹7,192.85 Cr
EBITDA
₹1,044.86 Cr₹1,116.04 Cr₹1,354.19 Cr₹1,825.43 Cr
₹143.57 Cr₹228.27 Cr₹539.12 Cr₹924.77 Cr
Diluted EPS
₹0.31₹0.49₹1.17₹1.98

Total expenses (as filed), Employee benefit expense, Other expenses, Other income have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Net income for Mar 2025 could not be checked against the company's own annual report: this page shows ₹539.12 Cr while the annual report gives ₹271.48 Cr (49.6% apart).

EBITDA for Mar 2025 could not be checked against the company's own annual report: this page shows ₹1,354.19 Cr while the annual report gives ₹562.40 Cr (58.5% apart).

09 · Balance Sheet

Annual

Line itemFY23FY24FY25FY26
₹10,590.48 Cr₹10,664.20 Cr₹11,050.66 Cr₹12,601.08 Cr
₹2,871.60 Cr₹2,531.71 Cr₹1,401.94 Cr₹1,110.54 Cr
Stockholders' equity
₹6,206.67 Cr₹6,443.13 Cr₹8,336.05 Cr₹9,659.10 Cr

CWIP, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2025-03-31, 2026-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2025-03-31, 2026-03-31, 2023-03-31, 2024-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2023-03-31, 2024-03-31 have no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY23FY24FY25FY26
₹856.78 Cr₹973.26 Cr₹1,214.07 Cr₹1,202.97 Cr
Investing cash flow
₹-129.06 Cr₹-469.06 Cr₹-964.21 Cr₹-710.69 Cr
₹-544.62 Cr₹-751.34 Cr₹-256.07 Cr₹-501.40 Cr
Capital expenditure
₹-143.68 Cr₹-182.73 Cr₹-124.44 Cr₹-192.21 Cr
End cash position
₹585.29 Cr₹344.13 Cr₹343.76 Cr₹357.92 Cr

Debt issued, Dividends paid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemNov 24–Mar 25(3Q)Jun 25–Sep 25(2Q)Dec 25–Jun 26(3Q)
Promoter82.39%67.38%50.95%
Public17.61%32.62%49.05%
Employee trusts0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
SAGILITY LIMITED₹19,820.75 Cr₹42.3419.22.059.6%0.11+29.1%-19.3%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

SAGILITY

Sagility Standalone September 2026 Net Sales at Rs 575.15 crore, up 16.98% Y-o-Y

Moneycontrol.com · 10 days ago

SAGILITY

Sagility Consolidated September 2026 Net Sales at Rs 2,032.10 crore, up 22.53% Y-o-Y

Moneycontrol.com · 17 days ago